Conversations with Jaguars - March 27 (20% Above Consensus, Distribution Partnership, Sector Dive) from expanding breast expansion Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: --- I have never read a more bullish note about AstraZeneca ($AZN) from BAML today than any time in my career. There is a Capital Markets Day (CMD) coming up in May which would unlock long term shareholder value. BAML is 20% above consensus. Additionally, this morning the company received approval in Japan for its breast cancer drug that takes about 17,000 lives in that country per year. Trade: Buy straight July 67.5 calls for $3.75 debit or less.nn--- Presenting a bull case for Celsius Holdings
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)